Quoin Pharmaceuticals Ltd. (QNRX)
QNRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.15
-4.82% on the day
Market cap
$19.9M
Nano cap
Revenue
No annual revenue filed since the period ending 2021-12-31
Net income
No annual revenue filed since the period ending 2021-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | QNRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | 2016 |
| SEC CIK | 0001671502 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials
No annual revenue filed since the period ending 2021-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-25 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-10-14 |
| Latest proxy | DEF 14A | 2026-10-02 |
Source: SEC EDGAR submissions feed, 575 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OPTH | Optimi Health Corp. Common Shares | $3.50 | -3.58% | $20.0M |
| COCP | Cocrystal Pharma Inc. | $1.08 | +1.89% | $20.8M |
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
| AYTU | Aytu BioPharma Inc. | $1.99 | +1.01% | $21.6M |
| NEUP | Neuphoria Therapeutics Inc. | $3.39 | +2.11% | $18.3M |
| AKTX | Akari Therapeutics plc ADS | $7.90 | -7.49% | $18.1M |
| TXMD | TherapeuticsMD Inc. | $1.96 | -2.97% | $22.7M |
| RADX | Radiopharm Theranostics Limited | $1.20 | +8.10% | $17.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier